Skip to main content
Enhanced Health AIv0.6.0
QuizMy PlanCalendarEvidenceSources
Session check

© 2026 Enhanced Health AI

MD-Designed No Data Sold
QuizSearchEvidenceSourcesHow We ScorePricingTermsPrivacy
Back to Database

Supplement

Phosphatidylserine

Supports broad cellular function with category-specific mechanisms.[2182,2852,2981, etc.]

Superscript reference numbers link to the Sources bibliography.

Strong Evidence
LongevityMetabolic HealthEnergy

Composite Rating

3.8/5

Blends evidence depth, community direction, safety friction, and completeness.

Evidence Intensity

100/100

High depth from human/RCT/meta counts

Community Direction

10

Mixed / Neutral • confidence Minimal

Safety Friction

100/100

High signal from adverse/interaction markers

Data Completeness

100%

Studies 11 • mentions 4 • links 21

Not medical advice. This product is for educational and informational purposes only. It does not diagnose, treat, cure, or prevent any disease and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition.

FDA disclaimer: These statements have not been evaluated by the Food and Drug Administration. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. Results may vary. Not intended for use by pregnant or nursing women, individuals under 18, or those with known medical conditions without physician consultation.

If you are experiencing a medical emergency, call 911 or your local emergency number immediately.

Implementation Blueprint

Goal alignment: Longevity, Metabolic Health, Energy.[601,747,974, etc.]

Dose guide: Human-study daily dose: 30 mg/day (moderate-confidence extraction from PubMed abstracts)..[601,747,974, etc.]

Category: other.[601,747,974, etc.]

Category

Other

Evidence Tier

HIGH

Daily Guide

Human-study daily dose: 30 mg/day (moderate-confidence extraction from PubMed abstracts).

Dosing Guide

Human-study daily dose: 30 mg/day (moderate-confidence extraction from PubMed abstracts).[2182,, etc.]

At-A-Glance Evidence Architecture[2182,2852,2981, etc.]

Clinical Depth

Humans: 203 • RCTs: 29 • Meta: 1

Cohort / Real-World

Cohort signals: 0

Safety Markers

Adverse signals: 726 • Interactions: 3,077

Evidence Tracking

Freshness, trend, and study timeline for this item

Evidence Tracking

Status

New Evidence

Trend

→ Stable evidence base

Depth

515 total studies · 3 recent

Timeline

20142025

Top Signal Metrics[2182,2852,2981, etc.]

Animal-only studies

5,785

In vitro / tissue

3,229

Interaction signals

3,077

Safety adverse signals

726

Total indexed

515

Human studies

203

Community Direction Mix[601,747,974, etc.]

Weighted direction score: 10 (Mixed / Neutral)

Evidence Quality Summary[2182,2852,2981, etc.]

High when >=2 human meta-analyses, or >=5 human RCTs with substantial human literature volume.

Animal-only studies

5,785

In vitro / tissue

3,229

Interaction signals

3,077

Safety adverse signals

726

Total indexed

515

Human studies

203

Randomized trials

29

Meta-analyses

1

Study Type Breakdown

Distribution of evidence by study design strength

Meta-AnalysesLevel 1a1
Randomized TrialsLevel 1b29
Human Studies (other)Level 3-4173
All IndexedAll levels515
100

Evidence Strength: High

Composite of study volume, RCTs, and meta-analyses

Top Human Studies[2182,2852,2981, etc.]

PMID 33539192 • 2021 Apr

Phosphatidylserine for the Treatment of Pediatric Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis.

J Altern Complement Med

Open PubMed

PMID 36558392 • 2022 Dec 8

A Magtein(®), Magnesium L-Threonate, -Based Formula Improves Brain Cognitive Functions in Healthy Chinese Adults.

Nutrients

Open PubMed

PMID 23495677 • 2014 Apr

The effect of phosphatidylserine administration on memory and symptoms of attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled clinical trial.

Community Report Frequency[601,747,974, etc.]

Benefit reports: 2

Adverse reports: 1

No-effect reports: 1

Mixed reports: 0

Unclear reports: 0

Signal confidence: 0.00

Top Reported Effects[601,747,974, etc.]

Benefits

  • Cognitive function support: 1
  • Memory enhancement: 1
  • Cortisol reduction: 1
  • ADHD symptom improvement: 1
  • Exercise recovery (cortisol modulation): 1
  • Neuroprotection: 1

Adverse

  • Very few contraindications: 1

No Effect

  • no noticeable effect: 1

Insufficient empirical signal for a directional adjustment.

Reddit evidence: 0 mentions (confidence 0.00).

Amazon signal: 0 products scanned (confidence 0.00).

GNC signal: 0 products scanned (confidence 0.00) [BLOCKED].

Community Evidence Examples[601,747,974, etc.]

aggregate • benefit

Aggregate community signal: 4 directional mentions (benefit 2, adverse 1, no-effect 1, mixed 0).

Open mention

Retail Signal Examples

amazon

Amazon search for Phosphatidylserine

Rating: n/a | Reviews: n/a

Open product

Primary Source Links

Evidence Sources

  • https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi?db=pubmed&term=(%22phosphatidylserine%22)%20AND%20(supplement*%5BTitle%2FAbstract%5D%20OR%20supplementation%5BTitle%2FAbstract%5D%20OR%20intake%5BTitle%2FAbstract%5D%20OR%20dietary%20supplements%5BMeSH%20Terms%5D)
  • https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi?db=pubmed&term=(%22phosphatidylserine%22)%20AND%20humans%5BMeSH%20Terms%5D%20AND%20(supplement*%5BTitle%2FAbstract%5D%20OR%20supplementation%5BTitle%2FAbstract%5D%20OR%20intake%5BTitle%2FAbstract%5D%20OR%20dietary%20supplements%5BMeSH%20Terms%5D)
  • https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi?db=pubmed&term=(%22phosphatidylserine%22)%20AND%20animals%5BMeSH%20Terms%5D%20NOT%20humans%5BMeSH%20Terms%5D

Scientific Evidence Notes[2182,2852,2981, etc.]

1. PubMed evidence summary: Phosphatidylserine

PUBMED • Humans + preclinical triage

Counts aggregated from automated literature sweep and tiering rules.

Outcome: Tier HIGH; humans 203, RCTs 29, meta-analyses 1.[2182,2852,2981, etc.]

Open source
2. Phosphatidylserine for the Treatment of Pediatric Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis.

PUBMED • 2021 • Human evidence curation set

PMID 33539192 from J Altern Complement Med.

Outcome: See linked PubMed abstract for methods and outcomes.[, etc.]

2852,
2981

Safety and Pitfalls

  • Elevated adverse/interactions signal in literature; review medications and conditions before use.[601,747,974, etc.]
  • High interaction-signal count detected in literature search.[601,747,974, etc.]
  • Legacy caution group: Very few contraindications[601,747,974, etc.]
Benefit
2 (50%)
Adverse1 (25%)
No Effect1 (25%)
Mixed0 (0%)

J Hum Nutr Diet

Open PubMed

PMID 39317299 • 2025 Jan 15

Effects of a food supplement containing phosphatidylserine on cognitive function in Chinese older adults with mild cognitive impairment: A randomized double-blind, placebo-controlled trial.

J Affect Disord

Open PubMed

PMID 38173190 • 2024 Apr

Phosphatidylserine enriched with polyunsaturated n-3 fatty acid supplementation for attention-deficit hyperactivity disorder in children and adolescents with epilepsy: A randomized placebo-controlled trial.

Epilepsia Open

Open PubMed

PMID 36014880 • 2022 Aug 17

Water-Soluble Tomato Concentrate, a Potential Antioxidant Supplement, Can Attenuate Platelet Apoptosis and Oxidative Stress in Healthy Middle-Aged and Elderly Adults: A Randomized, Double-Blinded, Crossover Clinical Trial.

Nutrients

Open PubMed

PMID 29576358 • 2018 Apr

A lecithin phosphatidylserine and phosphatidic acid complex (PAS) reduces symptoms of the premenstrual syndrome (PMS): Results of a randomized, placebo-controlled, double-blind clinical trial.

Clin Nutr ESPEN

Open PubMed

PMID 37603263 • 2023 Sep

Over the Counter Supplements for Memory: A Review of Available Evidence.

CNS Drugs

Open PubMed

PMID 40077790 • 2025 Mar 6

Exploring the Efficacy and Safety of Nutritional Supplements in Alzheimer's Disease.

Nutrients

Open PubMed

PMID 32370748 • 2020 May 5

Regulation of efferocytosis as a novel cancer therapy.

Cell Commun Signal

Open PubMed

PMID 28870843 • 2018 Oct

Phosphatidylserine: A cancer cell targeting biomarker.

Semin Cancer Biol

Open PubMed

PerimeterX / captcha block encountered.

Search fetch failed: Failed to fetch after retries: https://old.reddit.com/search.json?raw_json=1&sort=relevance&t=year&limit=12&q=%22phosphatidylserine%22%20(supplement%20OR%20dosage%20OR%20stack%20OR%20side%20effects%20OR%20review)%20(subreddit%3ASupplements%20OR%20subreddit%3ANootropics%20OR%20subreddit%3ABiohackers%20OR%20subreddit%3Alongevity%20OR%20subreddit%3ANutrition%20OR%20subreddit%3AHubermanLab%20OR%20subreddit%3ASleep%20OR%20subreddit%3AFitness%20OR%20subreddit%3Aketoscience%20OR%20subreddit%3AStackAdvice)

Fallback search failed: Failed to fetch after retries: https://old.reddit.com/search.json?raw_json=1&sort=comments&t=all&limit=16&q=%22phosphatidylserine%22%20(supplement%20OR%20capsule%20OR%20powder%20OR%20experience%20OR%20results%20OR%20side%20effects)

Broad search failed: Failed to fetch after retries: https://old.reddit.com/search.json?raw_json=1&sort=new&t=all&limit=16&q=phosphatidylserine

Use adverse/interactions PubMed signal counts for screening; perform clinician review before high-dose or multi-drug stack use.

Human-study daily dose signal: 30 mg/day (confidence MEDIUM).

Extracted from 2 dosing mentions across 1 PubMed studies (mg/day).

Imported legacy community score: 7.0/10 (heuristic mapping confidence 1.00).

Imported legacy monthly cost signal: ~$22.00.

Legacy community note: Respected in nootropic and cortisol-management communities. Athletes use it for cortisol control. Elderly report memory improvements. Often part of comprehensive brain health stacks.

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi?db=pubmed&term=(%22phosphatidylserine%22)%20AND%20humans%5BMeSH%20Terms%5D%20AND%20(supplement*%5BTitle%2FAbstract%5D%20OR%20supplementation%5BTitle%2FAbstract%5D%20OR%20intake%5BTitle%2FAbstract%5D%20OR%20dietary%20supplements%5BMeSH%20Terms%5D)%20AND%20randomized%20controlled%20trial%5BPublication%20Type%5D
  • https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi?db=pubmed&term=(%22phosphatidylserine%22)%20AND%20humans%5BMeSH%20Terms%5D%20AND%20(supplement*%5BTitle%2FAbstract%5D%20OR%20supplementation%5BTitle%2FAbstract%5D%20OR%20intake%5BTitle%2FAbstract%5D%20OR%20dietary%20supplements%5BMeSH%20Terms%5D)%20AND%20meta-analysis%5BPublication%20Type%5D
  • https://pubmed.ncbi.nlm.nih.gov/33539192/
  • https://pubmed.ncbi.nlm.nih.gov/36558392/
  • https://pubmed.ncbi.nlm.nih.gov/23495677/
  • https://pubmed.ncbi.nlm.nih.gov/39317299/
  • https://pubmed.ncbi.nlm.nih.gov/38173190/
  • https://pubmed.ncbi.nlm.nih.gov/36014880/
  • https://pubmed.ncbi.nlm.nih.gov/29576358/
  • https://pubmed.ncbi.nlm.nih.gov/37603263/
  • https://pubmed.ncbi.nlm.nih.gov/40077790/
  • https://pubmed.ncbi.nlm.nih.gov/32370748/
  • https://pubmed.ncbi.nlm.nih.gov/28870843/
  • https://pubmed.ncbi.nlm.nih.gov/?term=Phosphatidylserine
  • Community Sources

    • https://old.reddit.com/search.json?raw_json=1&sort=relevance&t=year&limit=12&q=%22phosphatidylserine%22%20(supplement%20OR%20dosage%20OR%20stack%20OR%20side%20effects%20OR%20review)%20(subreddit%3ASupplements%20OR%20subreddit%3ANootropics%20OR%20subreddit%3ABiohackers%20OR%20subreddit%3Alongevity%20OR%20subreddit%3ANutrition%20OR%20subreddit%3AHubermanLab%20OR%20subreddit%3ASleep%20OR%20subreddit%3AFitness%20OR%20subreddit%3Aketoscience%20OR%20subreddit%3AStackAdvice)
    • https://old.reddit.com/search.json?raw_json=1&sort=comments&t=all&limit=16&q=%22phosphatidylserine%22%20(supplement%20OR%20capsule%20OR%20powder%20OR%20experience%20OR%20results%20OR%20side%20effects)
    • https://old.reddit.com/search.json?raw_json=1&sort=new&t=all&limit=16&q=phosphatidylserine
    • https://www.reddit.com/search/?q=Phosphatidylserine
    2182,
    2852,
    2981
    Open source
    3. A Magtein(®), Magnesium L-Threonate, -Based Formula Improves Brain Cognitive Functions in Healthy Chinese Adults.

    PUBMED • 2022 • Human evidence curation set

    PMID 36558392 from Nutrients.

    Outcome: See linked PubMed abstract for methods and outcomes.[2182,2852,2981, etc.]

    Open source
    4. The effect of phosphatidylserine administration on memory and symptoms of attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled clinical trial.

    PUBMED • 2014 • Human evidence curation set

    PMID 23495677 from J Hum Nutr Diet.

    Outcome: See linked PubMed abstract for methods and outcomes.[2182,2852,2981, etc.]

    Open source
    5. Effects of a food supplement containing phosphatidylserine on cognitive function in Chinese older adults with mild cognitive impairment: A randomized double-blind, placebo-controlled trial.

    PUBMED • 2025 • Human evidence curation set

    PMID 39317299 from J Affect Disord.

    Outcome: See linked PubMed abstract for methods and outcomes.[2182,2852,2981, etc.]

    Open source
    6. Phosphatidylserine enriched with polyunsaturated n-3 fatty acid supplementation for attention-deficit hyperactivity disorder in children and adolescents with epilepsy: A randomized placebo-controlled trial.

    PUBMED • 2024 • Human evidence curation set

    PMID 38173190 from Epilepsia Open.

    Outcome: See linked PubMed abstract for methods and outcomes.[2182,2852,2981, etc.]

    Open source
    7. Water-Soluble Tomato Concentrate, a Potential Antioxidant Supplement, Can Attenuate Platelet Apoptosis and Oxidative Stress in Healthy Middle-Aged and Elderly Adults: A Randomized, Double-Blinded, Crossover Clinical Trial.

    PUBMED • 2022 • Human evidence curation set

    PMID 36014880 from Nutrients.

    Outcome: See linked PubMed abstract for methods and outcomes.[2182,2852,2981, etc.]

    Open source
    8. A lecithin phosphatidylserine and phosphatidic acid complex (PAS) reduces symptoms of the premenstrual syndrome (PMS): Results of a randomized, placebo-controlled, double-blind clinical trial.

    PUBMED • 2018 • Human evidence curation set

    PMID 29576358 from Clin Nutr ESPEN.

    Outcome: See linked PubMed abstract for methods and outcomes.[2182,2852,2981, etc.]

    Open source
    9. Over the Counter Supplements for Memory: A Review of Available Evidence.

    PUBMED • 2023 • Human evidence curation set

    PMID 37603263 from CNS Drugs.

    Outcome: See linked PubMed abstract for methods and outcomes.[2182,2852,2981, etc.]

    Open source
    10. Exploring the Efficacy and Safety of Nutritional Supplements in Alzheimer's Disease.

    PUBMED • 2025 • Human evidence curation set

    PMID 40077790 from Nutrients.

    Outcome: See linked PubMed abstract for methods and outcomes.[2182,2852,2981, etc.]

    Open source
    11. Regulation of efferocytosis as a novel cancer therapy.

    PUBMED • 2020 • Human evidence curation set

    PMID 32370748 from Cell Commun Signal.

    Outcome: See linked PubMed abstract for methods and outcomes.[2182,2852,2981, etc.]

    Open source
    12. Phosphatidylserine: A cancer cell targeting biomarker.

    PUBMED • 2018 • Human evidence curation set

    PMID 28870843 from Semin Cancer Biol.

    Outcome: See linked PubMed abstract for methods and outcomes.[2182,2852,2981, etc.]

    Open source